Close
Help




JOURNAL

Clinical Medicine Insights: Dermatology

71,819 Journal Article Views | Journal Analytics

An Appropriate Response to the Black-Box Warning: Corrective, Barrier Repair Therapy in Atopic Dermatitis

Submit a Paper



Publication Date: 09 Feb 2009

Journal: Clinical Medicine Insights: Dermatology

Citation: Clinical Medicine: Dermatology 2009:2 1-3

Abstract

Due to years of sophisticated research on T cell function, many dermatologists have viewed atopic dermatitis (AD) largely as an inflammatory disorder of TH1/TH2 imbalance. Hence, therapy has largely consisted of topical immunomodulators and/or steroids. The imposition of “black box” warnings about the potential toxicity associated with prolonged use of the immunosuppressive drugs, tacrolimus 0.1% or 0.3% ointment (Protopic®, Astellas Pharma U.S., Inc., Deerfield, IL) and pimecrolimus 1% cream (Elidel®, Novartis, Basel, Switzerland), as well as legitimate concerns about the adverse side effects of potent topical steroids, has stimulated a search for alternate forms of therapy. Recent genetic studies point to the primary role of a defective barrier to water loss and microbial invasion in the provocation of AD, creating a rationale for ‘barrier repair’ therapy. This approach utilizes topical applications of specific combination of the three (3) epidermal lipids that comprise the epidermal permeability barrier in a ratio (ceramide-dominant) that corrects the biochemical abnormality in AD.1,2 We review here both recent concerns about the topical immunomodulators, as well as the rationale for barrier repair therapy.


Downloads

PDF  (228.97 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)






What Your Colleagues Say About Clinical Medicine Insights: Dermatology
I highly recommend publication in Libertas Academia journals. The entire submission, review and publication process for our article in Clinical Medicine Insights: Dermatology was easy and quick.  The reviews were very professional and helpful and the publication fees were reasonable.  We also appreciate that our article is available online free of charge to anyone interested in it.
Dr Lisa Roche (New Jersey Department of Health and Senior Services, Trenton, NJ, USA)
More Testimonials

Quick Links


New article and journal news notification services